Outlining novel cellular adjuvant products for therapeutic vaccines against cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outlining novel cellular adjuvant products for therapeutic vaccines against cancer
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 8, Pages 1207-1220
Publisher
Informa UK Limited
Online
2011-08-22
DOI
10.1586/erv.11.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunization with recombinant MAGE-A3 protein combined with adjuvant systems AS15 or AS02B in patients with unresectable and progressive metastatic cutaneous melanoma: A randomized open-label phase II study of the EORTC Melanoma Group (16032- 18031)
- (2017) W. H. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Gamma-Chain Cytokines as Candidate Immune Modulators in Immune Therapies for Cancer
- (2010) Natasha M. Fewkes et al. CANCER JOURNAL
- Indoleamine 2,3-Dioxygenase
- (2010) Hatem Soliman et al. CANCER JOURNAL
- Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection
- (2010) Famke L. Schneiders et al. CLINICAL IMMUNOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Therapeutic HPV DNA vaccines
- (2010) Ken Lin et al. IMMUNOLOGIC RESEARCH
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- Pathogen recognition in the innate immune response
- (2009) Himanshu Kumar et al. BIOCHEMICAL JOURNAL
- Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
- (2009) T. Nicholaou et al. CLINICAL CANCER RESEARCH
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- Emulsion-based adjuvants for influenza vaccines
- (2009) Frederick R Vogel et al. Expert Review of Vaccines
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant activity mediated by iNKT cells
- (2009) Shinichiro Fujii et al. SEMINARS IN IMMUNOLOGY
- Advances in saponin-based adjuvants
- (2009) Hong-Xiang Sun et al. VACCINE
- ISCOMs and ISCOMATRIX™
- (2009) Hong-Xiang Sun et al. VACCINE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Mechanism of action of licensed vaccine adjuvants
- (2009) Elaine Tritto et al. VACCINE
- CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
- (2008) W. N. Haining et al. CLINICAL CANCER RESEARCH
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction
- (2008) Kingston H.G. Mills IMMUNOLOGY LETTERS
- History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
- (2007) Harry W. Herr et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search